Published in Magn Reson Med on July 06, 2012
Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage (2012) 1.78
Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging (2013) 1.57
Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med (2013) 1.10
Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging (2012) 0.94
J-difference editing of gamma-aminobutyric acid (GABA): simulated and experimental multiplet patterns. Magn Reson Med (2012) 0.93
Altered anterior cingulate neurochemistry in emerging adult binge drinkers with a history of alcohol-induced blackouts. Alcohol Clin Exp Res (2014) 0.91
HERMES: Hadamard encoding and reconstruction of MEGA-edited spectroscopy. Magn Reson Med (2016) 0.87
Multi-regional investigation of the relationship between functional MRI blood oxygenation level dependent (BOLD) activation and GABA concentration. PLoS One (2015) 0.87
Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS. J Magn Reson Imaging (2014) 0.86
Neurochemical changes within human early blind occipital cortex. Neuroscience (2013) 0.86
Prospective frequency correction for macromolecule-suppressed GABA editing at 3T. J Magn Reson Imaging (2016) 0.86
Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression. Magn Reson Med (2014) 0.85
Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease. J Magn Reson Imaging (2014) 0.81
Effects of Frequency Drift on the Quantification of Gamma-Aminobutyric Acid Using MEGA-PRESS. Sci Rep (2016) 0.80
Decreased auditory GABA+ concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy. Neuroimage (2014) 0.80
Reproducibility and effect of tissue composition on cerebellar γ-aminobutyric acid (GABA) MRS in an elderly population. NMR Biomed (2015) 0.80
Simultaneous edited MRS of GABA and glutathione. Neuroimage (2016) 0.79
Linking GABA and glutamate levels to cognitive skill acquisition during development. Hum Brain Mapp (2015) 0.79
Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects. Schizophr Bull (2014) 0.78
Normalizing data from GABA-edited MEGA-PRESS implementations at 3 Tesla. Magn Reson Imaging (2017) 0.76
Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus. J Neurosci (2015) 0.76
Increased Glutamate in Somatosensory Cortex in Functional Dyspepsia. Sci Rep (2017) 0.75
Spatial Hadamard encoding of J-edited spectroscopy using slice-selective editing pulses. NMR Biomed (2017) 0.75
In vivo estimation of gamma-aminobutyric acid levels in the neonatal brain. NMR Biomed (2016) 0.75
Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder. Transl Psychiatry (2017) 0.75
Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed (2000) 8.18
Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A (1993) 2.77
Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol (2010) 2.21
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry (2002) 1.99
Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91
In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2011) 1.91
Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex. J Magn Reson Imaging (2010) 1.86
Brain GABA editing without macromolecule contamination. Magn Reson Med (2001) 1.75
Regionally specific human GABA concentration correlates with tactile discrimination thresholds. J Neurosci (2011) 1.61
Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy. J Neurophysiol (2009) 1.55
A detailed analysis of localized J-difference GABA editing: theoretical and experimental study at 4 T. NMR Biomed (2008) 1.42
Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study. Schizophr Res (2009) 1.41
Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2012) 1.35
Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med (2006) 1.35
Efficient γ-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL. NMR Biomed (2011) 1.34
Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum (2012) 1.32
Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry (2011) 1.31
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Low brain GABA level is associated with poor seizure control. Ann Neurol (1996) 1.01
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Re-examining the brain regions crucial for orchestrating speech articulation. Brain (2004) 3.23
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology (2013) 2.79
Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke (2003) 2.61
Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage (2006) 2.21
Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91
Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med (2006) 1.91
Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci (2005) 1.75
Restoring cerebral blood flow reveals neural regions critical for naming. J Neurosci (2006) 1.60
Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2002) 1.59
Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging (2013) 1.57
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med (2007) 1.55
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging (2004) 1.40
Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31
Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci (2006) 1.30
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28
In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging (2002) 1.27
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging (2008) 1.16
Variability in subcortical aphasia is due to variable sites of cortical hypoperfusion. Brain Lang (2004) 1.15
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14
High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med (2010) 1.13
Acceleration of 1H MR metabolic imaging with compressed sensing. Radiology (2013) 1.10
Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med (2013) 1.10
Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging (2006) 1.09
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging (2005) 1.08
Subtraction artifacts and frequency (mis-)alignment in J-difference GABA editing. J Magn Reson Imaging (2012) 1.08
Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology (2003) 1.07
MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol (2011) 1.07
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage (2013) 1.06
Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol (2003) 1.05
Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging (2009) 1.05
Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol (2010) 1.05
Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging (2004) 1.04
Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke (2002) 1.04
Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med (2006) 1.02
White matter alterations in deficit schizophrenia. Neuropsychopharmacology (2008) 1.02
Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging (2006) 1.01
Correction of symptomatic cerebral malperfusion due to acute type I aortic dissection by transcarotid stenting of the innominate and carotid arteries. J Vasc Surg (2006) 1.00
Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol (2004) 0.99
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med (2008) 0.99
A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR Am J Roentgenol (2010) 0.98
Dual-band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med (2010) 0.98
Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med (2002) 0.98
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol (2010) 0.98
Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol (2007) 0.97
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov Disord (2012) 0.97
Neural correlates of modality-specific spatial extinction. J Cogn Neurosci (2006) 0.96
Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging (2012) 0.94
Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci (2012) 0.94
Quantitative SENSE-MRSI of the human brain. Magn Reson Imaging (2010) 0.94
Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging (2013) 0.93
Measurement of T1 and T2 in the cervical spinal cord at 3 tesla. Magn Reson Med (2008) 0.93
J-difference editing of gamma-aminobutyric acid (GABA): simulated and experimental multiplet patterns. Magn Reson Med (2012) 0.93
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat (2004) 0.92
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol (2013) 0.92
Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann Neurol (2009) 0.92
Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report. Neurosurgery (2002) 0.91
Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med (2005) 0.91
Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients. PLoS One (2012) 0.90
Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg (2006) 0.90
If J doesn't evolve, it won't J-resolve: J-PRESS with bandwidth-limited refocusing pulses. Magn Reson Med (2011) 0.90
Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol (2005) 0.90
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. Radiology (2010) 0.89
Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (2002) 0.89
Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol (2007) 0.88
Longitudinal and multi-echo transverse relaxation times of normal breast tissue at 3 Tesla. J Magn Reson Imaging (2010) 0.88
Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter. J Magn Reson Imaging (2005) 0.88
Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging. AJNR Am J Neuroradiol (2003) 0.88
Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging (2006) 0.87
Regions of neural dysfunction associated with impaired naming of actions and objects in acute stroke. Cogn Neuropsychol (2002) 0.85
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci U S A (2012) 0.85
Spin-echo magnetic resonance spectroscopic imaging at 7 T with frequency-modulated refocusing pulses. Magn Reson Med (2012) 0.85
Susceptibility-based analysis of dynamic gadolinium bolus perfusion MRI. Magn Reson Med (2014) 0.84
Marked reductions in visual evoked responses but not γ-aminobutyric acid concentrations or γ-band measures in remitted depression. Biol Psychiatry (2012) 0.84
GABA predicts inhibition of frequency-specific oscillations in schizophrenia. J Neuropsychiatry Clin Neurosci (2013) 0.84
Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma. Childs Nerv Syst (2004) 0.84
Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography. Magn Reson Med (2011) 0.83
A neurologic presentation of familial hemophagocytic lymphohistiocytosis which mimicked septic emboli to the brain. J Child Neurol (2007) 0.83
Quantitative proton MR spectroscopic imaging of the mesial temporal lobe. J Magn Reson Imaging (2004) 0.83
Neural regions essential for writing verbs. Nat Neurosci (2003) 0.82
1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results. Invest Radiol (2013) 0.82
MRI-guided vacuum-assisted breast biopsy: a phantom and patient evaluation of targeting accuracy. J Magn Reson Imaging (2009) 0.82
Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease. J Magn Reson Imaging (2014) 0.81
Readdressing synaptic pruning theory for schizophrenia: Combination of brain imaging and cell biology. Commun Integr Biol (2011) 0.81
Characteristic MR imaging changes in severe hypermethioninemic states. AJNR Am J Neuroradiol (2005) 0.80
Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology (2011) 0.80
Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection. J Neurovirol (2010) 0.80